Skip to main content

Peer Review reports

From: Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)

Original Submission
2 Dec 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Jan 2021 Reviewed Reviewer Report - Akihiko Matsumoto
10 Feb 2021 Reviewed Reviewer Report
5 Mar 2021 Author responded Author comments - Petros Grivas
Resubmission - Version 3
5 Mar 2021 Submitted Manuscript version 3
16 Mar 2021 Author responded Author comments - Petros Grivas
Resubmission - Version 4
16 Mar 2021 Submitted Manuscript version 4
Publishing
22 Mar 2021 Editorially accepted
24 May 2021 Article published 10.1186/s12885-021-08085-z

You can find further information about peer review here.

Back to article page